The Molecular Biology Society of Japan

The 42nd Annual Meeting of the Molecular Biology Society of Japan

The 42nd Annual Meeting of the Molecular Biology Society of Japan

Dec 3, 2019 - Dec 6, 2019
Fukuoka International Congress Center・Fukuoka sunpalace hotel & hall・Marine Messe Fukuoka

[2P-0570] Development of bispecific antibody drug for mesothelioma therapy

〇Yuki Kanamori1,2, Yasuhiro Moriwaki2, Shinako Takimoto1, Hidemi Misawa2, Kohzoh Imai1, Shoutaro Tsuji1 (1.Res Inst, Kanagawa Cancer Ctr, 2.Div Pharmacol, Dept Pharm, Keio Univ)

bispecific antibody, mesothelioma

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password